← News·MarketsMarkets

TNGX: Executive Chair Barbara Weber departs Tango Therapeutics, separation terms pending signature

The catalyst in focus for TNGX: Tango Therapeutics, Inc. confirmed in an August 6 SEC filing that Dr. Barbara Weber's employment as Executive Chair ended August 3, 2026, simultaneously triggering her resignation from…

NM
NewsMV Markets Desk
3 min read
7 August 2026Markets desk
Share this dispatch
TickersTNGX
Categoryregulatory

Filed via sec.gov

Keep reading

More from the markets desk